• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Novel perspective in transplantation therapy of mesenchymal stem cells: targeting the ferroptosis pathway.间质干细胞移植治疗的新视角:靶向铁死亡途径。
J Zhejiang Univ Sci B. 2023 Feb 15;24(2):115-129. doi: 10.1631/jzus.B2200410.
2
Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis.人脐带间充质干细胞来源的外泌体传递的 mir-129-5p 通过抑制铁死亡减轻炎症性肠病。
J Nanobiotechnology. 2023 Jun 12;21(1):188. doi: 10.1186/s12951-023-01951-x.
3
Suppressing Mesenchymal Stromal Cell Ferroptosis Via Targeting a Metabolism-Epigenetics Axis Corrects their Poor Retention and Insufficient Healing Benefits in the Injured Liver Milieu.通过靶向代谢-表观遗传学轴抑制间充质基质细胞铁死亡可纠正其在受损肝脏微环境中的保留不良和愈合作用不足。
Adv Sci (Weinh). 2023 May;10(13):e2206439. doi: 10.1002/advs.202206439. Epub 2023 Feb 19.
4
Mesenchymal stem cells and ferroptosis: Clinical opportunities and challenges.间充质干细胞与铁死亡:临床机遇与挑战
Heliyon. 2024 Feb 3;10(3):e25251. doi: 10.1016/j.heliyon.2024.e25251. eCollection 2024 Feb 15.
5
HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT/GPX4 axis.人脐带间充质干细胞来源的外泌体递送 Beclin1 通过调节 xCT/GPX4 轴诱导肝星状细胞发生铁死亡。
Cell Death Dis. 2022 Apr 8;13(4):319. doi: 10.1038/s41419-022-04764-2.
6
Human umbilical cord mesenchymal stem cells protect against ferroptosis in acute liver failure through the IGF1-hepcidin-FPN1 axis and inhibiting iron loading.人脐带间充质干细胞通过 IGF1-铁调素-FPN1 轴和抑制铁超载来防止急性肝衰竭中的铁死亡。
Acta Biochim Biophys Sin (Shanghai). 2024 Feb 25;56(2):280-290. doi: 10.3724/abbs.2023275.
7
Human placenta-derived mesenchymal stem cells trigger repair system in TAA-injured rat model via antioxidant effect.人胎盘源间充质干细胞通过抗氧化作用触发 TAA 损伤大鼠模型中的修复系统。
Aging (Albany NY). 2020 Dec 26;13(1):61-76. doi: 10.18632/aging.202348.
8
Ferroptotic MSCs protect mice against sepsis via promoting macrophage efferocytosis.铁死亡 MSC 通过促进巨噬细胞噬作用保护小鼠免于脓毒症。
Cell Death Dis. 2022 Sep 26;13(9):825. doi: 10.1038/s41419-022-05264-z.
9
Hypoxia-Induced Mesenchymal Stromal Cells Exhibit an Enhanced Therapeutic Effect on Radiation-Induced Lung Injury in Mice due to an Increased Proliferation Potential and Enhanced Antioxidant Ability.缺氧诱导的间充质基质细胞对小鼠放射性肺损伤具有增强的治疗效果,这归因于其增殖潜力的增加和抗氧化能力的增强。
Cell Physiol Biochem. 2017;44(4):1295-1310. doi: 10.1159/000485490. Epub 2017 Nov 29.
10
Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.携带有 QHREDGS 的自组装多肽作为心肌梗死后间充质干细胞移植的新型递送系统。
FASEB J. 2019 Jul;33(7):8306-8320. doi: 10.1096/fj.201801768RR. Epub 2019 Apr 10.

引用本文的文献

1
Application of mesenchymal stem cells in ferroptosis-related diseases.间充质干细胞在铁死亡相关疾病中的应用。
J Mol Med (Berl). 2025 Sep 3. doi: 10.1007/s00109-025-02591-4.
2
Prominin-2/FBXO22/BACH1 axis protects bone marrow mesenchymal stem cells against TBHP-induced ferroptosis and ameliorates intervertebral disc degeneration.Prominin-2/FBXO22/BACH1轴保护骨髓间充质干细胞免受叔丁基过氧化氢诱导的铁死亡,并改善椎间盘退变。
Stem Cell Res Ther. 2025 Jul 1;16(1):340. doi: 10.1186/s13287-025-04453-9.
3
Targeting prominin-2/BACH1/GLS pathway to inhibit oxidative stress-induced ferroptosis of bone mesenchymal stem cells.靶向prominin-2/BACH1/GLS通路以抑制氧化应激诱导的骨髓间充质干细胞铁死亡
Stem Cell Res Ther. 2025 Apr 29;16(1):213. doi: 10.1186/s13287-025-04326-1.
4
Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus.靶向铁死亡:间充质干细胞治疗1型糖尿病的机遇与挑战
Stem Cell Res Ther. 2025 Feb 4;16(1):47. doi: 10.1186/s13287-025-04188-7.
5
Targeting ferroptosis to enhance the efficacy of mesenchymal stem cell-based treatments for intervertebral disc degeneration.靶向铁死亡以增强基于间充质干细胞的椎间盘退变治疗效果
Int J Biol Sci. 2025 Jan 20;21(3):1222-1241. doi: 10.7150/ijbs.107021. eCollection 2025.
6
Olig2 single-colony-derived cranial bone-marrow mesenchymal stem cells achieve improved regeneration in a cuprizone-induced demyelination mouse model.少突胶质细胞转录因子2单克隆来源的颅骨骨髓间充质干细胞在铜螯合剂诱导的脱髓鞘小鼠模型中实现了更好的再生。
J Zhejiang Univ Sci B. 2024 Sep 25;25(12):1108-1114. doi: 10.1631/jzus.B2300790.
7
Human umbilical cord mesenchymal stem cells restore chemotherapy-induced premature ovarian failure by inhibiting ferroptosis in vitro ovarian culture system.人脐带间充质干细胞通过抑制体外卵巢培养系统中的铁死亡来恢复化疗诱导的卵巢早衰。
Reprod Biol Endocrinol. 2024 Nov 7;22(1):137. doi: 10.1186/s12958-024-01310-x.
8
MiR-4465-modified mesenchymal stem cell-derived small extracellular vesicles inhibit liver fibrosis development via targeting LOXL2 expression.miR-4465 修饰的间充质干细胞衍生的小细胞外囊泡通过靶向 LOXL2 表达抑制肝纤维化发展。
J Zhejiang Univ Sci B. 2024 May 17;25(7):594-604. doi: 10.1631/jzus.B2300305.
9
Human umbilical cord mesenchymal stem cells attenuate diabetic nephropathy through the IGF1R-CHK2-p53 signalling axis in male rats with type 2 diabetes mellitus.人脐带间充质干细胞通过 IGF1R-CHK2-p53 信号通路减轻 2 型糖尿病雄性大鼠糖尿病肾病。
J Zhejiang Univ Sci B. 2024 Jul 10;25(7):568-580. doi: 10.1631/jzus.B2300182.

本文引用的文献

1
Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns.铁代谢、铁死亡和癌症中的长链非编码 RNA:已知和未知。
J Zhejiang Univ Sci B. 2022 Oct 15;23(10):844-862. doi: 10.1631/jzus.B2200194.
2
Ferroptosis is involved in regulating perioperative neurocognitive disorders: emerging perspectives.铁死亡参与调控围手术期神经认知障碍:新视角。
J Neuroinflammation. 2022 Sep 6;19(1):219. doi: 10.1186/s12974-022-02570-3.
3
LPS preconditioning of MSC-CM improves protection against hypoxia/reoxygenation-induced damage in H9c2 cells partly via HMGB1/Bach1 signalling.脂多糖预处理 MSC-CM 可部分通过 HMGB1/Bach1 信号通路改善 H9c2 细胞缺氧/复氧诱导的损伤。
Clin Exp Pharmacol Physiol. 2022 Dec;49(12):1319-1333. doi: 10.1111/1440-1681.13714. Epub 2022 Sep 18.
4
NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells.NCOA4介导的铁蛋白自噬参与电离辐射诱导的肠上皮细胞铁死亡。
Redox Biol. 2022 Sep;55:102413. doi: 10.1016/j.redox.2022.102413. Epub 2022 Jul 30.
5
Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton's Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury.视黄酸预处理的牙髓间充质干细胞对肾缺血/再灌注损伤的保护作用的可能潜在机制。
Cells. 2022 Jun 22;11(13):1997. doi: 10.3390/cells11131997.
6
Ferroptosis and its role in cardiomyopathy.铁死亡及其在心肌病中的作用。
Biomed Pharmacother. 2022 Sep;153:113279. doi: 10.1016/j.biopha.2022.113279. Epub 2022 Jun 20.
7
Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer.铁调节对雌激素受体阳性乳腺癌间质干细胞诱导耐药的影响。
Oncogene. 2022 Jul;41(29):3705-3718. doi: 10.1038/s41388-022-02385-9. Epub 2022 Jun 22.
8
A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.一种基于 Fe(III)-卟啉-奥沙利铂(IV)的纳米平台,用于增强铁死亡和联合治疗。
J Control Release. 2022 Aug;348:660-671. doi: 10.1016/j.jconrel.2022.06.019. Epub 2022 Jun 20.
9
Hydroxytyrosol Alleviated Hypoxia-Mediated PC12 Cell Damage through Activating PI3K/AKT/mTOR-HIF-1 Signaling.羟基酪醇通过激活 PI3K/AKT/mTOR-HIF-1 信号减轻低氧介导的 PC12 细胞损伤。
Oxid Med Cell Longev. 2022 Jun 3;2022:8673728. doi: 10.1155/2022/8673728. eCollection 2022.
10
Mesenchymal stem cells against intestinal ischemia-reperfusion injury: a systematic review and meta-analysis of preclinical studies.间质干细胞治疗肠缺血再灌注损伤:临床前研究的系统评价和荟萃分析。
Stem Cell Res Ther. 2022 May 26;13(1):216. doi: 10.1186/s13287-022-02896-y.

间质干细胞移植治疗的新视角:靶向铁死亡途径。

Novel perspective in transplantation therapy of mesenchymal stem cells: targeting the ferroptosis pathway.

机构信息

Medical School of Southeast University, Southeast University, Nanjing 210009, China.

Department of Spine Surgery, Zhongda Hospital Affiliated to Southeast University, School of Medicine, Southeast University, Nanjing 210009, China.

出版信息

J Zhejiang Univ Sci B. 2023 Feb 15;24(2):115-129. doi: 10.1631/jzus.B2200410.

DOI:10.1631/jzus.B2200410
PMID:36751698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10260286/
Abstract

Ex vivo culture-amplified mesenchymal stem cells (MSCs) have been studied because of their capacity for healing tissue injury. MSC transplantation is a valid approach for promoting the repair of damaged tissues and replacement of lost cells or to safeguard surviving cells, but currently the efficiency of MSC transplantation is constrained by the extensive loss of MSCs during the short post-transplantation period. Hence, strategies to increase the efficacy of MSC treatment are urgently needed. Iron overload, reactive oxygen species deposition, and decreased antioxidant capacity suppress the proliferation and regeneration of MSCs, thereby hastening cell death. Notably, oxidative stress (OS) and deficient antioxidant defense induced by iron overload can result in ferroptosis. Ferroptosis may inhibit cell survival after MSC transplantation, thereby reducing clinical efficacy. In this review, we explore the role of ferroptosis in MSC performance. Given that little research has focused on ferroptosis in transplanted MSCs, further study is urgently needed to enhance the in vivo implantation, function, and duration of MSCs.

摘要

体外培养扩增的间充质干细胞(MSCs)因其具有修复组织损伤的能力而受到研究关注。MSC 移植是促进受损组织修复、替代丢失细胞或保护存活细胞的有效方法,但目前 MSC 移植的效率受到移植后短时间内大量 MSC 丢失的限制。因此,迫切需要增加 MSC 治疗效果的策略。铁过载、活性氧沉积和抗氧化能力下降抑制 MSC 的增殖和再生,从而加速细胞死亡。值得注意的是,铁过载引起的氧化应激(OS)和抗氧化防御不足会导致铁死亡。铁死亡可能会抑制 MSC 移植后的细胞存活,从而降低临床疗效。在本综述中,我们探讨了铁死亡在 MSC 性能中的作用。鉴于铁死亡在移植 MSC 中的研究较少,迫切需要进一步研究以增强 MSC 的体内植入、功能和持续时间。